Second Sight Med

EYES NASDAQ
0.7730
+0.0030
+0.39%
After Hours: 0.8100 +0.037 +4.79% 16:12 08/21 EDT
Open
0.7750
Prev Close
0.7700
High
0.7750
Low
0.7600
Volume
51.98K
Avg Vol (3M)
203.54K
52 Week High
1.980
52 Week Low
0.6351
% Turnover
0.04%
Market Cap
96.31M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Second Sight Med EYES stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company intends to develop Orion Visual Cortical Prosthesis which provides useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease or forms of cancer and trauma. Its product, The Argus II Retinal Prosthesis System (The Argus II) provides electrical stimulation of the retina to induce visual perception in blind individuals and helps in treating outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. The Company's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals.
MORE >

Recently

Name
Price
%Change